HCA

HCA

Price: 378.51

Company and Business Model

HCA Healthcare, Inc. operates as a healthcare services provider, primarily focused on owning and operating hospitals and related healthcare facilities. Its core services include inpatient and outpatient care, emergency services, and surgical services. The company generates revenue mainly from patient services, including admissions and surgeries, as well as ancillary services such as laboratory and imaging services. HCA operates in various segments, including acute care hospitals and outpatient services, contributing significantly to its overall revenue.

Investment Profile

The investment profile of HCA is more aligned with value investors, given its relatively stable revenue streams and modest dividend yield. The stock may appeal to those seeking a balance between income and capital appreciation, although recent performance indicates potential challenges. Investors should consider the company's risk factors and market conditions when evaluating its suitability for their portfolios.

Official website

Fundamental metrics (experimental)

EPS (TTM) — earnings per share for the last 12 months, $
29.25 OK
Revenue QoQ — quarter-over-quarter revenue growth
-2.1%
EPS surprise
0.4% in line
20d volatility
1.8% stable
Dividend yield
1.0% low last ex-date: 2026-06-16
FMP / FinFeed data updated: 2026-06-11

Forecast impact

negative
Target Lowered · Truist Financial · valid until 2026-07-04 · updated 2026-06-11
Target +10.6% target fill 90.4%
Reaction D5 -4.61% · D10 pending market trust
Impact Potential -4 · Risk +3 up to 30 days or until target is reached
Reco: Sell Potential: 29 Risk: 75 Updated: 2026-06-11 05:20
How recommendation works
Why AI thinks so:
Weak momentum and fundamentals raise significant risk concerns.

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
AI recommendation changes
Date Before After Reason
2026-06-09 02:41 Hold Sell Weak fundamentals and negative momentum raise significant concerns.
2026-05-30 02:40 Sell Hold Weak fundamentals and negative momentum indicate high risk.
2026-05-16 02:38 Hold Sell Weak fundamentals and negative momentum signal high risk.
Analyst forecasts
Date Analyst Action Target Price Then
2026-06-04 11:53 Truist Financial Target Lowered — → 413 367.69
2026-06-04 10:50 Bernstein Target Lowered 503 → 413 363.23
2026-04-27 12:48 Stephens Target Lowered 560 → 530 444.76

Nothing yet